Clinical service
Precision Oncology Consultation
A structured discussion of the molecular and clinical picture in a cancer case, and of the questions it raises.
Who it is for
- Patients and families holding molecular or genomic results they want to understand.
- Patients weighing several treatment paths who want the evidence set out.
- Clinicians seeking a molecular perspective on a case in discussion.
What is reviewed
- Clinical history and disease course to date
- Pathology, immunohistochemistry and where relevant a request for slide review
- Imaging reports and how they correspond to the clinical picture
- Available molecular, genomic and multi-omic reports
- Germline findings and family history where relevant
- Circulating tumour DNA and serial molecular results where available
- Prior treatment, sequence, tolerability and documented response
- Current medication, including interactions relevant to systemic therapy
- The relevant scientific literature and trial landscape
What is delivered
- A structured summary of the case as the documents describe it
- Interpretation of molecular findings in clinical context, with evidence levels stated
- A clear separation of findings that are established, emerging, or unsupported
- Identification of testing gaps — what has not been assessed that might matter
- Potentially relevant biomarkers and clinical-trial avenues
- Monitoring and longitudinal considerations
- A framework of questions to take to the treating team
- Where you wish, direct discussion with your treating clinician
How this works alongside your care
- Analysis and interpretation are provided to you and, where you wish, directly to your treating team — who continue to prescribe, administer and direct your treatment.
- The work sits alongside your treating oncologist and is designed to strengthen that relationship rather than sit outside it.
- It is built for considered review. Anything acute or time-critical belongs with your treating team or your local emergency service, who can act immediately.
- It sets out what the evidence supports and where it remains uncertain. It does not forecast how a particular cancer will respond.
How to begin
Getting started
Nothing is charged for an enquiry, and scope is agreed in writing before any work starts.
Enquiries begin with a short message describing the situation and the question. From there, the documentation needed is agreed, and a scope and timeline are confirmed before any work starts.
The document checklist sets out what is typically needed. Missing items are worth identifying at the outset rather than mid-review.
Other services
Molecular Report Review
A detailed reading of a next-generation sequencing or molecular profiling report, including what the assay could and could not detect.
Cancer Second Opinion
An independent re-reading of the clinical, pathological and molecular record in a complex case.
Precision Oncology Analysis & Strategy
The flagship service: a structured review of the clinical, pathological, molecular and evidentiary dimensions of a complex cancer case.